UNSW Lowy Cancer Research Centre

Last updated

UNSW Lowy Cancer Research Centre
MottoGiving hope through collaboration
Established28 May 2010 (2010-05-28)
DirectorProfessor Philip Hogg
Faculty UNSW Sydney
Adjunct faculty Children's Cancer Institute
Location
Corner of Botany and High Streets, Randwick, New South Wales, Australia
Website www.lowycancerresearchcentre.unsw.edu.au

The Lowy Cancer Research Centre is a facility at The University of New South Wales. It is Australia's first facility bringing together researchers in childhood and adult cancers, and one of the country's largest cancer research facilities, housing up to 400 researchers. The centre, named for businessman Frank Lowy, who donated $10 million towards the project, was officially opened on 28 May 2010. [1] It is home to researchers from the UNSW Faculty of Medicine and Children's Cancer Institute Australia. The inaugural director is Professor Philip Hogg, winner of the Cancer Institute NSW Premier's Award for Outstanding Cancer Research in 2009. [2] [3]

Contents

Building facilities

The Lowy Cancer Research Centre was built with funding from numerous private and government organisations, including Frank Lowy, who gifted $10 million; [1] the Australian Government, that granted $13.3 million; [4] the Australian Cancer Research Foundation (ACRF), that granted $3.1 million for the establishment of the ACRF Drug Discovery Centre for Childhood Cancer; [5] [6] and the bulk of the $127 million cost was generated from the sale of the Little Bay sporting fields at UNSW, which were sold for $103 million. [7] [8] Lahznimmo Architects, in association with Wilson Architects, designed The Lowy Cancer Research Centre with environmental sustainability in mind. [9]

Official opening

The centre was officially opened on 28 May 2010 by the Prime Minister Kevin Rudd and the NSW Premier Kristina Keneally. [10] At the official opening Rudd said: [11]

"To take us further we need research. And that is where the Lowy Centre will come into its own.

Kevin Rudd, Prime Minister of Australia, May 2010

Research impact

Lowy Cancer Symposium

The Lowy Cancer Symposium is a biennial cancer conference, hosted by the Lowy Cancer Research Centre in Sydney. Designed for basic research scientists, oncologists and other healthcare professionals, this cancer symposium is Australia's only Cancer Drug Discovery Symposium and focuses on the three key phases of cancer therapeutic development: discovery, pre-clinical and clinical. [12] [13]

The symposium brings together Australian and international leading cancer researchers to discuss real-time breakthroughs in cancer treatments and cures. [14]

The first Lowy Cancer Symposium with the theme Discovering Cancer Therapeutics was held on 16–18 May 2010 leading up to the official opening of the new Centre. Among the notable guests were Nobel Laureate K Barry Sharpless, Vishva Dixit, and Nicholas Dracopoli. [15]

Launch celebrations for the new ACRF Drug Discovery for Childhood Cancer, which is housed in the Lowy Cancer Research Centre, were also held during the symposium. [5]

The second Lowy Cancer Symposium was held 15–17 May 2013 at UNSW, highlighting Australasia's cancer research breakthroughs and showcasing some of the best international cancer research, including an address from Dr Lewis Cantley, director of the Cancer Center at Weill Cornell Medical College in New York. [16]

See also

Related Research Articles

<span class="mw-page-title-main">University of New South Wales</span> Australian university

The University of New South Wales (UNSW), also known as UNSW Sydney, is a public research university based in Sydney, New South Wales, Australia. It is one of the founding members of Group of Eight, a coalition of Australian research-intensive universities.

The Institute of Cancer Research is a public research institute and a member institution of the University of London in London, United Kingdom, specialising in oncology. It was founded in 1909 as a research department of the Royal Marsden Hospital and joined the University of London in 2003. It has been responsible for a number of breakthrough discoveries, including that the basic cause of cancer is damage to DNA.

<span class="mw-page-title-main">WEHI</span> Medical research institute in Victoria, Australia

WEHI, previously known as the Walter and Eliza Hall Institute of Medical Research, and as the Walter and Eliza Hall Institute, is Australia's oldest medical research institute. Sir Frank Macfarlane Burnet, who won the Nobel Prize in 1960 for his work in immunology, was director from 1944 to 1965. Burnet developed the ideas of clonal selection and acquired immune tolerance. Later, Professor Donald Metcalf discovered and characterised colony-stimulating factors. As of 2015, the institute hosted more than 750 researchers who work to understand, prevent and treat diseases including blood, breast and ovarian cancers; inflammatory diseases (autoimmunity) such as rheumatoid arthritis, type 1 diabetes and coeliac disease; and infectious diseases such as malaria, HIV and hepatitis B and C.

<span class="mw-page-title-main">Frank Lowy</span> Australian businessman, founder and chairman of Westfield

Sir Frank P. Lowy is an Australian-Israeli businessman of Jewish Slovak-Hungarian origins and the former long-time Chairman of Westfield Corporation, a global shopping centre company with US$29.3 billion of assets under management in the United States, United Kingdom and Europe.

Mark Sebastian Wainwright is an Australian chemical engineer and emeritus professor of the University of New South Wales, and institutional leader within the Australian academic and technological sectors. He served as seventh vice chancellor and president of the UNSW from 2004 to 2006. In 2004 he was appointed a member of the Order of Australia for services to chemical engineering as a researcher and academic, and to tertiary education. In 2007 he was awarded an honorary doctorate of science by the University of New South Wales. He was born 20 Oct.,1943.

The Faculty of Law and Justice of the University of New South Wales is a law school situated in Sydney, Australia. It is widely regarded as one of Australia's top law schools. The 2021 QS World University Rankings rank the UNSW Law Faculty 13th in the world, first for undergraduate law in Australia, 2nd overall in Australia and 3rd in the Asia-Pacific region, and the 2021 Times Higher Education subject rankings also rank it second in Australia, making it the top ranked law school in New South Wales according to both tables, as well as being the top undergraduate Law school in the country.

<span class="mw-page-title-main">Bob Carr</span> Former Premier of New South Wales

Robert John Carr is an Australian retired politician and journalist who served as the 39th Premier of New South Wales from 1995 to 2005, as the leader of the NSW Branch of the Australian Labor Party (ALP). He later entered federal politics as a New South Wales senator, and served as Minister for Foreign Affairs from 2012 to 2013. Following his departure from politics he served as the Director of the Australia-China Relations Institute (ACRI) from 2014 to 2019 at the University of Technology Sydney (UTS).

The Indigenous Law Centre (ILC), formerly the Aboriginal Law Research Unit and Aboriginal Law Centre, is part of the Law Faculty at the University of New South Wales. It develops and coordinates research, teaching and information services in the multi-disciplinary area of Indigenous peoples and the law, and publishes two major journals: the Australian Indigenous Law Review and the Indigenous Law Bulletin. It is the only Indigenous law research centre in Australia.

<span class="mw-page-title-main">Alan Dupont</span>

Alan Anthony Dupont is an Australian international security expert, Defence and National Security Advocate for the Northern Territory and company director who has been the CEO of geopolitical risk consultancy the Cognoscenti Group since 2016. He is also contributing national security editor for The Australian newspaper, adjunct professor at the University of New South Wales (UNSW), a non-resident senior fellow at the Atlantic Council in Washington, and the Lowy Institute in Sydney and a fellow at the Hinrich Foundation.

Levon Michael Khachigian is an Australian medical research scientist notable for his work in vascular cell and molecular biology. He is a Professor in the Faculty of Medicine at the University of New South Wales.

<span class="mw-page-title-main">Katharina Gaus</span> Australian immunologist (1972–2021)

Katharina Gaus was a German-Australian immunologist and molecular microscopist. She was an NHMRC Senior Research Fellow and founding head of the Cellular Membrane Biology Lab, part of the Centre for Vascular Research at the University of New South Wales. Gaus used new super-resolution fluorescence microscopes to examine the plasma membrane within intact living cells, and study cell signalling at the level of single molecules to better understand how cells "make decisions". A key discovery of Gaus and her team was how T-cells decide to switch on the body's immune system to attack diseases. Her work is of importance to the development of drugs that can work with T-cells in support of the immune system.

Michelle Haber is an Australian cancer researcher.

Vanessa Hayes is a geneticist conducting research into cancer genomics and comparative human genomics. She leads a research group at the Garvan Institute of Medical Research in Sydney Australia and holds the Petre Chair of Prostate Cancer Research at the University of Sydney.

<span class="mw-page-title-main">Steven Lowy</span> Australian executive

Steven Mark Lowy is the former co-Chief Executive Officer of Westfield Corporation, a leading global shopping centre company that was acquired by French company Unibail-Rodamco in 2018 in what was one of the largest transactions in Australian corporate history. His principal activities now focus on investments associated with the Lowy family’s private company, Lowy Financial Group, as well as a number of philanthropic and community roles including as Chairman of the World Board of Trustees of Keren Heysod-United Israel Appeal and President of the Hakoah Club.

<span class="mw-page-title-main">Ian Jacobs (oncologist)</span>

Ian Jacobs is an academic, medical doctor, gynaecological oncologist, charity founder and university leader from the UK, with dual British and Australian citizenship.

<span class="mw-page-title-main">Methamphetamine use in Australia</span>

Under Australia's law, methamphetamine is a Schedule 8 drug, available for medical use but restricted in manufacture, supply, and possession. The drug is sought after to give oneself a ‘high’ or a ‘rush’ in their body. Users of this drug often feel senses of exhilaration and arousal as the brain is flooded with monoamines. Methamphetamine has many names not only in Australia, but also around the world. These include chalk, crypto, gear, getgo, tweak, and cristy, although the two most common ones in Australia today are speed and ice. Speed refers to the powder form of the drug, while ice refers to the highly purified, crystalline form. The powder form is often diluted with adulterants including glucose and sucrose.

<span class="mw-page-title-main">Children's Cancer Institute</span>

Children's Cancer Institute is an Australian medical research institute wholly dedicated to the prevention and treatment of childhood cancer. Established in 1976, the Institute is affililiated with both the University of New South Wales and Sydney Children's Hospital and is located in Randwick, Sydney, New South Wales.

Maria Kavallaris is an Australian scientist, based at the University of New South Wales' Children's Cancer Institute, where she is best known for her contributions to the field of cancer research. On 25 January 2019, Kavallaris was appointed a member of the Order of Australia.

Eileen Baldry is an Australian criminologist and social justice advocate. She is Deputy Vice-Chancellor Equity Diversity and Inclusion and Professor of Criminology at the University of New South Wales (UNSW).

References

  1. 1 2 "Prime Minister opens Lowy Cancer Research Centre at the University of New South Wales" (PDF) (Press release). Australian Cancer Research Foundation. 2010. Retrieved 28 May 2010.
  2. "Welcome | Lowy Cancer Research Centre".
  3. "Archived copy" (PDF). Archived from the original (PDF) on 11 November 2011. Retrieved 28 May 2013.{{cite web}}: CS1 maint: archived copy as title (link)
  4. "Lowy donates $10 million to cancer research". J-Wire. Retrieved 10 June 2010.
  5. 1 2 "ACRF Drug Discovery Centre for Childhood Cancer". ACRF Drug Discovery Centre for Childhood Cancer. Retrieved 10 June 2010.
  6. "Australia leading the way with cancer research" (PDF) (Press release). Children's Cancer Institute Australia (CCIA). 2010. Retrieved 10 June 2010.
  7. "Financial Report" (PDF). The University of New South Wales. 2007.
  8. "Annual Report" (PDF). The University of New South Wales. 2008.
  9. "$127 Million Lowy Cancer Research Centre opens". NSW Government. 28 May 2010. Retrieved 28 May 2010.
  10. "Major new cancer centre opens in Sydney". Life Scientist. Retrieved 10 June 2010.
  11. "Kevin Rudd speech opening the Lowy Cancer Research Centre". Australia.to News. Retrieved 10 June 2010.
  12. "World leaders in cancer research gather for Lowy Symposium" (PDF) (Press release). Lowy Cancer Research Centre. Retrieved 10 June 2010.
  13. "Australasia's cancer research breakthroughs showcased at 2nd Lowy Cancer Symposium | Medicine". Archived from the original on 18 April 2019. Retrieved 28 May 2013.
  14. "Lowy Symposium: Global Cancer Research Leaders Discuss Real Time Breakthroughs" (Press release). Australian Cancer Research Foundation. Retrieved 10 June 2010.
  15. "Lowy Symposium: Discovering cancer therapeutics" (PDF). ASN Events. Retrieved 10 June 2010.
  16. "Lowy Cancer Symposium". 2013.